International Conference on Rare Diseases and Orphan Drugs Announces New Board of Directors
Diverse body of expertise to tackle the challenges of rare diseases (Stockholm, Sweden) – November 14, 2016. The International Conference on Rare Diseases and Orphan Drugs (ICORD), the global rare disease society dedicated improving the welfare of patients with rare diseases and their families world-wide, announced five new officers and ten new board members following its annual meeting in Cape Town, South Africa. Read more here.
Meet with us at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco January 9-12, 201
If you are attending the conference and would like to learn about how Diligentia can support your commercial business objectives, email us to arrange an on-site meeting: joff@diligentiastrategy.com
